Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thiamine for metabolic syndrome in military personnel
IRCT20180201038585N5Phase 3Completed
- Sponsor
- Baqiyatallah University of Medical Sciences
- Start
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of thiamine in cardiometabolic risk (CMR), sponsored by Baqiyatallah University of Medical Sciences. Primary endpoints: Change in blood pressure, Change in lipid profile and 2 more. Started Oct 2019; status: completed.
02
Drugs
thiamine
03
Conditions
cardiometabolic risk (CMR)
Beyond the preview
Go deeper on IRCT20180201038585N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180201038585N5.